Glaukos Corporation (GKOS) Cash Flow Statement

The gap between net income and operating cash flow is stark: in 2026Q2, net loss of $18.4M contrasts with $14.8M operating cash flow, driven by $28.9M in stock-based compensation and $11.2M in D&A. This suggests that while GAAP losses persist, cash burn is less severe than reported, though the negative OCF/NI ratio in most quarters indicates that working capital outflows often offset these non-cash add-backs.

The trajectory shows improvement: FCF margin improved from -40.7% in 2024Q1 to 6.5% in 2026Q2, but this is highly volatile quarter-to-quarter, with negative FCF in five of the last ten quarters. The positive FCF in 2026Q2 appears driven by a favorable working capital swing, not sustainable operational gains, as revenue growth accelerates but cash conversion remains inconsistent.

With CapEx/Revenue consistently below 3%, GKOS's capital expenditure is minimal relative to its revenue base, suggesting that the company's growth is driven more by R&D and commercial expenses than physical assets. This low capital intensity supports positive FCF potential, but investors should monitor whether capitalized development costs are understating true investment.

The working capital line is the primary driver of quarterly cash flow variability, with large swings in both directions. This suggests that GKOS's cash flow is heavily influenced by the timing of receivables and inventory, which may obscure the underlying operational cash generation. Investors should focus on the trend in operating cash flow excluding working capital to assess true earnings quality.

Capital deployment is almost entirely directed toward organic growth, with negligible buybacks and no dividends. The small buyback in 2026Q2 may be opportunistic, but the overall pattern suggests management is prioritizing investment in R&D and commercialization over returning capital to shareholders, consistent with the company's early-stage profitability profile.